Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrast-Enhanced Ultrasound for Kidney Transplant
NCT02911714Phase 1Terminated
- Sponsor
- University of Utah
- Start
- Feb 2018
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of sulfur hexafluoride in kidney transplantation (2 arms), sponsored by University of Utah. Primary endpoints: Biomarker-Defined Delayed Graft Function and Biopsy-Proven Acute Rejection. Started Feb 2018; status: terminated.
02
Drugs
sulfur hexafluoride
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT02911714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02911714.